ABSTRACT. The prediction, measurement, and monitoring of neurologic toxicity of antibacterial agents is an exceedingly difficult matter. In this study we investigated if in vitro exposure of cultured brain cells to antibacterial drugs could predict neurotoxicity in man. Effects of antibiotics used for therapy of bacterial CNS infections on growth and differentiation in dissociated rat brain cell cultures were studied over 24 days in culture, the drugs being added from 10 to 17 days in culture, the main differentiation phase of rat CNS cells. Our results demonstrated a reversible inhibition of cerebral sulfate transferase activity ( p < 0.001 or < 0.01) and to a lesser extent ( p < 0.001 or NS) of DNA synthesis in brain cell cultures by the highest concentrations studied of amikacin, cefuroxime, and ceftazidime which correspond to peak cerebrospinal fluid values attained by intraventricular therapy in patients. Accumulation of DNA reflects brain cell growth whereas cerebral sulfate transferase activity parallels brain cell differentiation. Our findings indicate that intraventricular therapy could be more toxic with amikacin, cefuroxime, and ceftazidime than with penicillin, chloramphenicol, or ceftriaxone. Thus, this brain cell culture model might become a supplement, complement, or even alternative technique for neurotoxicity assessment of antibiotics with proven or potential value for therapy of CNS infections. (Pediatr Res 24: 367-372,1988) Abbreviations BCC, brain cell culture CSF, cerebrospinal fluid DIC, days in culture CST, cerebral sulfate transferase reviews of case reports (1, 2). CNS toxicity is a well-described complication of intraventricular antibiotic therapy for gramnegative bacillary ventriculitis and CSF shunt infections (l,2,4-7). Animal toxicity tests bear a relatively poor predictive value for neurotoxicity in man and require the use of a high number of animals (4, 5, (8) (9) (10) . Therefore, back-shifting of neurotoxicity tests from the human or animal situation to a relatively simple and reproducible system in vitro was the principal aim of the present research.
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There are many reports presenting evidence of dose-dependent antiproliferative effects of various antibiotics on cultured eucaryotic cells. The cell types studied include human fibroblasts (1 1), bone marrow cells (12) , and dissociated brain cells (1 3) . As in vitro correlative of dose-related marrow suppression by chloramphenicol it was found several decades ago that this drug inhibits mitochondria1 protein synthesis not only in bacteria but also in proliferating bone marrow cells (14, 15) . More recently, the inhibition of cell proliferation has most often been studied for the @-lactam antibiotics on cultured human myeloid percursor and lymphoid cells, the clinical consequences being neutropenia and impairment of cellular and humoral immune responses induced by 6-lactams (12, 16-1 8) .
The purpose of our investigation was to monitor the effects of antibiotics on growth and differentiation in dissociated rat BCC which might help to predict human neurotoxicity. Standard and newer antibacterial agents used for meningitis and ventriculitis therapy were studied. The drug concentrations were chosen such as to represent peak values attained in ventricular CSF during intravenous therapy (19) (20) (21) (22) , and their 5 and 10 times multiples that correspond to the concentration range reached by intraventricular antibiotic administration (23) (24) (25) .
Potential adverse drug effects on BCC were studied during the essential differentiation phase of rat CNS cells between day 10 and 17 in culture. From day 17 to 24 in culture any regeneration capacity was assumed to become manifest.
The neurotoxicity of antibacterial agents is often overlooked MATERIALS AND METHODS or misinterpreted because of its relative infrequency and because its prediction, measurement, and monitoring is extremely difiCultures. Dissociated brain cells were prepared from newborn cult (1-3). The neurological side effects of antibiotics include rats (Sprague-Dawley) as previously described (26) except that CNS toxicity (convulsions, encephalopathy, neuropsychiatric no trypsin was used. A 10-ml aliquot of cell suspension (lo5 symptoms), cranial nerve toxicity (optic neuritis, deafness, ver-cells/ml) was seeded into culture dishes that immediately before tigo), peripheral nerve toxicity (paresthesia, motor weakness, had been exposed for 1 h to Poly-L-Lysine (Sigma P-1524) and sensory impairment), and neuromuscular blockade. Postmarket-washed for 1 h with sterile water. The medium used was modified ing surveillance for such adverse drug reactions has rarely been Eagle medium (Dulbecco) supplemented with 10% fetal calf performed and clinical knowledge is almost exclusively based on serum. This basic culture medium contained no antibiotics and was changed on 3, Addition of antimicrobial agents. The drugs and concentrations tested are listed in Table 1 . The pure antibiotics were obtained through the hospital pharmacy and were available as either sodium salt (penicillin, cephalosporins, chloramphenicol) or sulfate (aminoglycosides) to be dissolved in sterile water. Generic names, trade names, and manufacturers of the study drugs were: benzylpenicillin sodium (penicillin G, Hoechst), streptomycin sulfate (Streptothenat, Griinenthal), amikacin sulfate (Amikin, Bristol-Myers), chloramphenicol sodium succinate (Chloromycetin, Parke-Davis), cefuroxime sodium (Zinacef, Glaxo), ceftriaxone sodium (Rocephin, Roche), and ceftazidime sodium (Fortam, Glaxo). Aliquots of concentrated stock solutions were stored at -20" C.
The antimicrobial agents were added to the BCC medium to get the final concentration per ml of medium given in Table 1 on DIC 10, 13, and 15. Antibiotics were mixed with the medium by agitation of the dish. From DIC 17 on, only antibiotic-free medium was used again. Exposure to antibiotic in test BCC was therefore 7 days (DIC 10-17).
Analytical methods. At DIC 10 (days 0-10 control and test BCC without antibiotics), 14 and 17 (days 10-17 exposure to antibiotics in test BCC), and 24 (days 17-24 control and test BCC without antibiotics) the cultured cells were harvested by scraping with a rubber policeman, washed, and centrifuged. The * Concentrations of penicillin G given in IU/ml; 20 IU/ml = 1 1.2 pg/ ml, 100 IU/ml = 56 pglml; 200 IU/ml = 112 pg/ml.
cell sediments were kept frozen at -20" C until assayed within 3 wk. Complete homogenization of brain cells was secured by thawing and addition of 200 p1 of homogenization buffer (50 mM NaH2 PO4, 1 mM EDTA Na2, Triton X-100 195, pH 7.0). Total protein was determined by the method of Lowry et al. (27) , and total DNA according to Hinegardner (28) . Activity of CST was assayed as previously described (29) . Accumulation of protein and DNA reflects brain cell growth (26) whereas CST activity parallels brain cell differentiation (29) . Drugs assays. Antibiotic concentrations were measured in culture medium and brain cell lysates of some of the BCC experiments with the aim to determine half-life in medium and penetration into brain cells. The assay methods used were enzyme immunoassay technique for amikacin (30) and high-pressure liquid chromatography for cefuroxime (3 l), ceftriaxone (32) , and ceftazidime (33) . Assays of penicillin, streptomycin, and chloramphenicol were not performed.
Statistics. Significance between test and control BCC measurements of protein and DNA content and CST activity was determined using the paired Student's t test on two to four separate experiments performed in triplicate. The results were confirmed by the paired Wilcoxon test (34) .
RESULTS
Cell growth and differentiation. Macro-and microscopic examinations indicated regular growth of morphologically normal brain cells. To compare the sensitivity of the present rat BCC model to the previously used mouse BCC model (1 3), the experiment with the penicillin/streptomycin combination (200 IU/50 pg/ml culture medium) generally used to maintain sterility in cell cultures was first repeated. As shown in Table 2 this drug combination compared to control reduced significantly DNA content at DIC 14 ( p < 0.05) and CST activity at DIC 17 ( p < 0.00 1) as reported before (1 3).
The lower and intermediate drug concentrations tested (Table  1 ) had no effect on the different parameters studied (12 experiments in triplicate, data not shown). The results of protein concentration (mg/culture), DNA concentration (pglculture), and CST activity (pmol/h/mg protein) measurements at DIC 10, 14, 17, and 24 in the six experiments with the highest antibiotic concentrations studied are listed in Tables 2 and 3 as   Table 2 For the cephalosporins, the great majority (>go%) of drug assays in cell lysates did not detect any measurable concentration, the lower limit of detection being 1.0 pglml.
DISCUSSION
The results of the present study demonstrated reversible inhibition of CST activity and to a lesser extent of DNA synthesis in BCC by the highest concentrations studied of amikacin, cefuroxime, and ceftazidime. Accumulation of protein and DNA reflects brain cell growth (26) whereas CST activity parallels brain cell differentiation (29) . The antibacterial agents were added to BCC from 10 to 17 DIC which corresponds to the essential differentiation phase of rat CNS cells (26) . Dissociated BCC consist to a major part of oligodendrocytes besides astrocytes and neurons (35) . Our data suggest that certain antibiotics exhibit a dosedependent suppressive effect on differentiation and to a lesser extent on proliferation of oligodendrocytes in rat BCC. Both of these drug actions showed complete regeneration during the antibiotic-free period from 17 to 24 DIC and did not affect cell viability. These experimental data could indicate that the drugs principally interact with enzyme activity. This interpretation of drug mechanism is consistent with recent publications demonstrating dose-dependent inhibition of the replicative DNA polymerase enzyme in eucaryotic cells by p-lactam antibiotics (17, 18) . Interestingly, the same research group has established a rank order of p-lactams for their inhibitory capacity on bone marrow cultures (12, 18) with good correlation to clinical induction of neutropenia. The suppressive effects of the p-lactams studied in our BCC model followed the same rank order: ceftazidme > cefuroxime > ceftriaxone and penicillin. It is possible that the negative drug effects on cell proliferation and differentiation are more pronounced in cultured cell populations more rapidly dividing than rat BCC.
The inhibitory potency of @-lactams on in vitro granulopoiesis seems to be substantially enhanced by drug degradation (16) . However, the convulsant effect, like the antimicrobial effect, depends on the presence of the intact p-lactam ring (2, 36) . It has been shown in animal experiments that penicillinase-treated penicillin G is no more epileptogenic (37) .
The most pronounced effect in our experiments was the inhibition of CST activity by amikacin in the concentration of 100 pg/ml medium. The primary mode of bactericidal action of aminoglycosides is due to their specific attachment to ribosomes and subsequent disruption of the translation mechanism of the cell (38, 39) . It has been speculated that these mechanisms also account for the use of aminoglycosides as inhibitors of eucaryotic cells in the development of interspecific cloning vectors (39) . Reduced CST activity could reflect impaired CST synthesis due to ribosomal interaction of amikacin in the BCC model.
Antibiotic concentration measurements in culture medium confirmed the anticipated potency loss within 2 days of approximately 10% for amikacin and approximately 50% for the cephalosporin compounds. Attempts to assess drug cell penetration in this in vitro model were based on antibiotic determination in cell lysates (40) . The assumed high cell penetration of amikacin was confirmed whereas the cephalosporin data proved to be too variable to allow any conclusion concerning brain cell-associated antibiotic. Penetration of antibiotics into eucaryotic cells is extremely complex and depends on a variety of factors such as lipid solubility, protein binding, molecular size, and structure of both, cell membrane and intracellular organelles (40, 41) . In addition to limited brain cell penetration also binding to cellular structures and potency loss could have been responsible for the in >90% nondetectable cephalosporin concentrations in the cell IN VITRO NEUROTOX ICITY OF ANTIBIOTICS 37 1 lysates. A possible relation between cell penetration and suppressive effects of antibiotics in this BCC model is not assessable by our data.
The limited clinical knowledge on neurotoxicity of antimicrobial agents (1-3) and difficulties in extrapolating in vivo animal models (4, 5, (8) (9) (10) prompted the present in vitro research. The advantages of in vitro assessment are better reproducibility and smaller number of variables. Prognosis of gram-negative bacillary ventriculitis and CSF shunt infections remains relatively poor. The major therapeutic problems of these CNS infections are antibiotic resistance of involved, often nosocomially acquired, gram-negative and gram-positive pathogens, and limited drug penetration into CSF because of narrow therapeutic drug index or only low-grade meningeal inflammation (6, 7) . Therefore, to produce larger antibiotic concentrations in CSF direct drug inoculation is often recommended in addition to systemic therapy (6, 7, 23, 24, 42) . Neurotoxicity represents a potential hazard for intraventricular antibiotic administration and has been clinically and experimentally repeatedly observed ( 1, 2, 4, 23-25 ). Histopathologic changes in rabbits due to gentamicin included ependymal and brain cell damages (4, 5) . The highest antibiotic concentrations studied in our experiments correspond to the peak values in CSF attained by intraventricular administration in patients (6, 7, 23, 24, 42) . To imitate the clinical situation of intraventricular therapy the study drugs were taken from regular injectable drug vials as sodium or sulfate salts. Therefore, our experiments do not allow to exclude effects of the salt components on BCC.
We conclude that the in vitro phenomena observed in these studies could have some predictive value for clinical neurotoxicity. The no-effect levels may be of at least equal significance as the toxic-effect levels. Simple extrapolation of results of toxic effects from in vitro to in vivo situation and across species is obviously unrealistic (9) . The major limitations of our in vitro test system for drug neurotoxicity are elimination of blood-brain barrier, lack of metabolic and elimination functions, and absence of inflammation. We suggest that the clinical use of antimicrobial agents that produce significant inhibition of cell growth and differentiation in this BCC model implies close monitoring for potential neurotoxicity, especially during intraventricular drug administration.
Inclusion of histopathologic and immunofluorescent studies (33, analysis for degradation products of antibiotics (16, 18) , and evaluation of the salt component of antibiotic might add to the predictive value of our model. These studies are part of our planned further investigations.
Implications. Our findings indicate that intraventricular therapy could produce more neurotoxicity with amikacin, cefuroxime, and ceftazidime than with penicillin, chloramphenicol, or ceftriaxone. So far, clinical experience with intraventricular amikacin, cefuroxime, ceftazidime, and also ceftriaxone administration is very scant and, to our knowledge, neurologic side effects have not been reported. Careful monitoring for neurotoxic signs and symptoms is mandatory in such patients. We suggest that the sensible use of our BCC model could represent an important component in the early assessment for neurotoxicity of antimicrobial agents with proven or potential value for therapy of CNS infections.
